Web Analytics
Cổ phiếu CRL (NYSE) | CHARLES RIVER LABORATORIES – Phân tích Deepscope
MARKET

Select Market Data Region

CRL — CHARLES RIVER LABORATORIES (Healthcare >> Diagnostics & Research)

CRL FAQ

What is CRL's P/E ratio?

CHARLES RIVER LABORATORIES (CRL) currently trades at a P/E ratio of 78.87.

What is CRL's ROE?

CHARLES RIVER LABORATORIES reports a Return on Equity (ROE) of -6.28%.

What is CRL's dividend yield?

CHARLES RIVER LABORATORIES offers a dividend yield of 0.00%.

What is CRL's Deepscope Quality Score?

Deepscope rates CRL's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CRL?

Deepscope's AI Timing Score for CRL is 63 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CRL belong to?

CHARLES RIVER LABORATORIES is classified under the Healthcare >> Diagnostics & Research sector on the NYSE exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

CRL

CHARLES RIVER LABORATORIES
USD 179.87
5.08 (2.91%) Day Change
78.87
P/E
0.91
D/E
-6.3%
ROE
-2.4%
ROA
0.00%
Div Yield
-0.14
PEG
USD 179.87
Price
5.08 (2.91%)
Day Change
NEWS SCORE: 98

CRL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

23

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng 39%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 179.87
  PBV / Sector
2.82 / -23.97
  Earning Per Share -3.94
  PE / Sector
78.87 / 36.92
  PEG or PE/Growth / Sector
-0.14 / 1.37
  Average 1M Daily Value
142.17 M
GREAT
  Average 1W Daily Value
142.88 M
GREAT
Yếu tố Kỹ thuật 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 58%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 54%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-4.59 / 12.69
  NPM Average (%) / Sector
3.16 / 7.99
  NPM Change Average (%) / Sector
-397.52 / -5.21
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-2.39 / 11.23
  ROA Average (%) / Sector
1.58 / -82.28
  ROA Change Average (%) / Sector
-416.98 / 159.98
  ROE (%) / Sector
-6.28 / -86.57
  ROE Average (%) / Sector
3.80 / -2.21
  ROE Change Average (%) / Sector
-428.14 / -44.18
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.26
  Dividend Average (%) / Sector
N/A / 1.20
  Dividend Change Average (%) / Sector
N/A / 7.52
Chi tiết đăng ký
X
  Analyze Date 2026-06-04 09:24:09
  Symbol CRL
  Name CHARLES RIVER LABORATORIES
  Sector Healthcare >> Diagnostics & Research
  Market NYSE
  Listed Shares 48.17 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 8,419.24 / 31,486.64
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 251 Ballardvale Street, Wilmington, MA, United States, 01887

Phone: 781 222 6000

Website: https://www.criver.com

Employees: 18,300

Sector: Healthcare >> Diagnostics & Research

Description: Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

ME vs SECTOR Healthcare >> Diagnostics & Research

CRL (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
CRL
CRL
USD 179.87 (2.91%)
+ Watch + Port Chart